Grace Therapeutics, Inc. is a late-stage biopharmaceutical company dedicated to the development of innovative drug delivery technologies aimed at improving treatments for rare and orphan diseases. With a focus on enhancing the performance of existing therapies, the company seeks to expedite the onset of action, augment efficacy, minimize side effects, and provide more user-friendly delivery options for patients.
Company Values
Grace Therapeutics stands out through its commitment to addressing rare diseases with novel delivery methods that promise significant improvements in patient outcomes.